CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis  Ana Hennino, PhD, Catherine Jean-Decoster,

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Detection of novel occupational wood allergens in locust wood dust (Robinia pseudoacacia L.)  Sabine Kespohl, PhD, Rolf Merget, MD, Axel Overlack, MD,
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events  Keiichi Yamanaka, MD, PhD, Hitoshi.
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D
Atopic dermatitis: Age and race do matter!
Increased TGF-β2 in severe asthma with eosinophilia
Ulf Darsow, MD, Dieter Vieluf, MD, Johannes Ring, MD, PhD 
Calcitonin gene-related peptide– and vascular endothelial growth factor–positive inflammatory cells in late-phase allergic skin reactions in atopic subjects 
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,
Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages  Susanne Mommert, PhD, Karl Gregor, MD, Kristine.
Eosinophil extracellular DNA traps in skin diseases
Eniko Sonkoly, MD, Anja Muller, MD, Antti I
Is 9 more than 2 also in allergic airway inflammation?
Pathergy response to skin prick testing
Allergic skin diseases
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Silvana Balzar, MD, Matthew Strand, PhD, Diane Rhodes, PhD, Sally E
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation  David F. Choy, BS, Daniel K. Hsu, PhD,
T-cell involvement in delayed-type hypersensitivity reactions to infliximab  Maria Jose Torres, MD, PhD, Patrícia Chaves, PhD, Inmaculada Doña, MD, Natalia.
Yuichi Teraki, MD, Aika Sakurai, MD, Seiichi Izaki, MD 
The National Biome Initiative: An allergy perspective
Evaluation of Food Allergy in Patients with Atopic Dermatitis
A network-based analysis of the late-phase reaction of the skin
Serum tryptase levels in atopic and nonatopic children
Thymic stromal lymphopoietin–activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis  Wen Hao Wu, PhD,
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
What are the best outcome measurements for atopic eczema
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis  Natalija Novak, MD,
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
What is an “eosinophilic phenotype” of asthma?
Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma  Sheena D. Brown, PhD, Lou Ann Brown, PhD, Susan Stephenson, PhD,
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis  Marie Tauber, MD, Stefana.
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
New pathways for itching in patients with atopic dermatitis?
Chemokines and their receptors in allergic disease
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection  Saurabh Mehandru, MD, Klara Tenner-Racz, MD, Paul Racz, MD, PhD, Martin.
Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma 
Risk of oral food challenges
The Editors' Choice Journal of Allergy and Clinical Immunology
Reply Journal of Allergy and Clinical Immunology
Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis  Eva Gros, MSc, Caroline Bussmann,
Biju Thomas, MD, Robert Anthony Hirst, PhD, Mina H
IgE-mediated and T cell–mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis  Peter Schmid-Grendelmeier, MD, Sabine Flückiger,
Epicutaneous application of house dust mite induces thymic stromal lymphopoietin in nonlesional skin of patients with atopic dermatitis  Janneke Landheer,
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis  Andrea L. Jones, MD, Douglas Curran-Everett, PhD,
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization.
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis  Janine Bilsborough, PhD, Donald.
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Presentation transcript:

CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis  Ana Hennino, PhD, Catherine Jean-Decoster, PhD, Françoise Giordano-Labadie, MD, Sabine Debeer, PhD, Béatrice Vanbervliet, PhD, Aurore Rozières, PhD, Anne-Marie Schmitt, MD, PhD, Jean-François Nicolas, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 4, Pages 1064-1067 (April 2011) DOI: 10.1016/j.jaci.2010.11.022 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 A, Summary of the 9 patients included in the study. ∗Positivity of the APT (according to European Task Force on Atopic Dermatitis consensus) at 9 and 48 hours as well as at 72 hours in the preselection of the study. The severity of the disease is defined as mild (<500 pg/mL) and moderate (>500 pg/mL) according to chemokine (C-C motif) ligand 17 (CCL17) serum level (∗∗normal range, approximately 200 pg/mL). The numbers of CD8+ (B) and CD3+ (C) T cells/mm2 in skin in control (ctrl) or HDM APT are represented at 9 and 48 hours. D, Comparison between the number of CD8+ T cells and eosinophils at 9 and 48 hours in HDM APT. Journal of Allergy and Clinical Immunology 2011 127, 1064-1067DOI: (10.1016/j.jaci.2010.11.022) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 A, Immunostaining of HDM APT or control APT in patient 9 with anti-CD8, anti-CD3, and anti–granzyme B (GrzB). Original magnification is ×200. Inset is magnified view (×400). Quantification of the number of CD8+, CD3+, and granzyme B+ cells/mm2 in HDM compared with control (ctrl) in whole skin (B) and in epidermis (C). Journal of Allergy and Clinical Immunology 2011 127, 1064-1067DOI: (10.1016/j.jaci.2010.11.022) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Quantification of the mRNA by the TaqMan low-density array technique for several molecules indicated in the figure. Total mRNA was extracted from APT to HDM and control. The mRNA was normalized to 3 housekeeping genes (hypoxanthine phosphoribosyltransferase [HPRT], ubiquitin, and actin). Results are expressed in fold increase in HDM APT compared with control (petrolatum). A, C, D, Fold increase of indicated molecules at 9 hours. B, Fold increase of CD8 and CD4 mRNA at 9 and 48 hours. CCL, Chemokine (C-C motif) ligand; GNLY, granulysine; GZMB, granzyme B; NK, natural killer; PRF1, perforine. Journal of Allergy and Clinical Immunology 2011 127, 1064-1067DOI: (10.1016/j.jaci.2010.11.022) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions